• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • AB Science – Masitinib
      • BrainStorm Cell Therapeutics – NurOwn
      • Clene Nanomedicine – CNM-Au8
      • ILB – Tikomed
      • Kadimastem – AstroRx
      • Mitsubishi Tanabe Pharma America – Oral Edaravone
      • Neuronata-R/Lenzumestrocel
      • NeuroSense – PrimeC
      • Neuvivo – NP001
      • Prilenia Therapeutics – Pridopidine
      • SOD1 Therapies & Trials
      • SPG302
      • T Regulatory Cell Therapies
      • Ulefnersen – Ionis Pharmaceuticals
    • Approved Drugs
      • Nuedexta
      • Radicava/Edaravone
      • Riluzole/Tiglutik
      • Rozebalamin/Methylcobalamin
      • Tofersen/Qalsody
    • Drugs No Longer in Development
      • Amylyx – AMX0035
      • Collaborative Medicinal Development – CuATSM
      • Cytokinetics – Reldesemtiv
      • Orphazyme – Arimoclomol
      • TUDCA Trial
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Genetics

ALS/MND can affect families in different ways. In about 90% of cases, there is only one person in a family with ALS/MND. This is called sporadic ALS/MND. In about 10% of cases, more than one person in the same family is affected. This is known as hereditary or familial ALS/MND and may be linked to a change in a gene that runs in a family.

For some families, understanding hereditary ALS/MND may be an important next step. It can help explain why the condition affects more than one person in the same family and why symptoms may differ across family members. It may also help families understand what information they may want to explore next.

Even in cases of sporadic ALS/MND, meaning there is no known family history, genetics may still be relevant. This is because a genetic change may still be present even when ALS/MND appears to affect only one person in a family. This is one reason information about genetics may be useful to a wider group of people and families.

The materials below support different needs and different levels of interest. They include brief explanations, visual resources, and additional information for those who want to learn more about genetics in ALS/MND.


Starting with the basics

To better understand genetics, it can be helpful to start with the basics. The visual explainers below introduce the genome, DNA, genes, and chromosomes, and provide a simple foundation for the rest of this section.

  • What is your genome? ( PDF): This infographic introduces the genome and shows how DNA, genes, chromosomes, RNA, and proteins are connected. It explains how genetic information is stored and used, helping build a foundation for genetics in ALS/MND.
  • Introduction to Genetics (PDF): This infographic introduces genetics and how genetic changes can be passed through families in different ways. It helps explain why some are affected, others are unaffected carriers, and why hereditary conditions look different in each family.

Understanding genetics in ALS/MND

The visual explainers below build on these basic concepts and focus more directly on how genetics may relate to ALS/MND and why it may matter for individuals and families.

  • Why is genetics relevant to ALS/MND? (PDF): This infographic shows how family history and genetic causes do not always fit simple categories. It explains the difference between hereditary and sporadic ALS/MND, varied inheritance patterns, and that a genetic cause can be found even without clear family history.
  • Can genes affect the type of ALS/MND? (PDF): This infographic explains penetrance, which means that carrying a genetic change does not always mean a person will develop ALS/MND. It also shows that genes can lead to different types of ALS/MND across individuals.

Learn more about genetics in ALS/MND

These resources provide broader introductions to genetics and inherited ALS/MND. They may be helpful for readers who want to build on the visual explainers and explore these topics in more detail.

  • Introduction to ALS/MND Genetics (video): This Alliance webinar gives an overview of genetics in ALS/MND and the current ALS/MND landscape. It is intended to help people living with ALS/MND and their families build a basic understanding of genetics, what it may mean for them, and what options may be available.
  • Inherited MND: Introduction (webpage): This resource from the MND Association introduces inherited ALS/MND and is useful for readers wanting more after the visual explainers.
  • Familial ALS (PDF): This ALS Association booklet provides broader information on familial ALS/MND and may suit readers seeking a detailed resource.

Primary Sidebar

  • David Watson, Scotland

    David Watson, Scotland

  • Robbie Caliste, UK

    Robbie Caliste, UK

  • Rudiger Hanemann, Germany

    Rudiger Hanemann, Germany

  • Murat Morali, Turkey

    Murat Morali, Turkey

  • Timmy, Belgium

    Timmy, Belgium

  • Jean Waters, UK

    Jean Waters, UK

  • Steve

    Steve

  • Chun Ju Xiao, China

    Chun Ju Xiao, China

  • Maria Lucia Wood Saldanha, Brazil

    Maria Lucia Wood Saldanha, Brazil

  • Dawn Morton, Scotland

    Dawn Morton, Scotland

  • Marcel R. Wernard, Netherlands

    Marcel R. Wernard, Netherlands

  • Feng Gin Sun, China

    Feng Gin Sun, China

  • Andrea Zicchieri, Italy

    Andrea Zicchieri, Italy
    AndreaZicchieri_conSLAncioItaly

  • Animesh Kumar, India

    Animesh Kumar, India

  • Hiroshi Matsuyama, Japan

    Hiroshi Matsuyama, Japan

  • Shera Mukherjee, India

    Shera Mukherjee, India

  • Alberto Baez Murillo, Colombia

    Alberto Baez Murillo, Colombia

  • Liong Ting Ngu, Malaysia

    Liong Ting Ngu, Malaysia

  • Malu Araujo Ribeiro, Brazil

    Malu Araujo Ribeiro, Brazil

  • Brigitte Wernli, Switzerland

    Brigitte Wernli, Switzerland

  • Mike Cels, Canada

    Mike Cels, Canada

  • Joyce Rusinak, USA

    Joyce Rusinak, USA

  • Horacio Fritzer, Argentina

    Horacio Fritzer, Argentina

  • Kris Van Reusel, Belgium

    Kris Van Reusel, Belgium

  • Cassio Fernando da Silva, Brazil

    Cassio Fernando da Silva, Brazil

  • Colm Francis Davis, Ireland

    Colm Francis Davis, Ireland

  • Mauril Bélanger, Canada

    Mauril Bélanger, Canada

  • Catherine Pearce, Australia

    Catherine Pearce, Australia

  • Jette Odgaard Villemoes, Denmark

    Jette Odgaard Villemoes, Denmark

  • Frank Taylor, USA

    Frank Taylor, USA

  • Paul Launer, USA

    Paul Launer, USA

  • Irene McCaughey, Australia

    Irene McCaughey, Australia

  • Lee Millard, England

    Lee Millard, England

  • David Hall, USA

    David Hall, USA

  • Diana Fernandez, Argentina

    Diana Fernandez, Argentina

  • Sébastien Batiot, France

    Sébastien Batiot, France

  • Frank Bos, Netherlands

    Frank Bos, Netherlands

  • Yolanda Armendariz, Mexico

    Yolanda Armendariz, Mexico

  • Dick Dayton, USA

    Dick Dayton, USA

  • Ann Nicol, USA

    Ann Nicol, USA

  • Chris McCauley, Canada

    Chris McCauley, Canada

  • Joanne Pratt, Australia

    Joanne Pratt, Australia

  • Chirag Walia, India

    Chirag Walia, India
    ChiragWalia

  • Richard Clark, New Zealand

    Richard Clark, New Zealand

  • JP

    JP

  • Maurice LeClerc, Canada

    Maurice LeClerc, Canada

  • Carlos Alberto Arango, Colombia

    Carlos Alberto Arango, Colombia

  • Manuel Arn, Switzerland

    Manuel Arn, Switzerland

  • John Sweeney, USA

    John Sweeney, USA

  • Olga, Argentina

    Olga, Argentina

Learn more about the March of Faces

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login